News and Trends 18 Jul 2022
Enterome and Nestlé Health Science to work on food allergies and inflammatory bowel disease
Enterome, a clinical stage biopharmaceutical company developing immunomodulatory drugs based on its bacterial Mimicry drug discovery platform, has signed a strategic R&D collaboration and license agreement with Nestlé Health Science…